GlassScriptPhysician profile
Matthew G Clarke
NPI 1497912877
$5,665.70
in general payments reported to CMS, 2019-2025
13 companies · $826 in 2025
The $826 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,369 · 2020: $103 · 2021: $724 · 2022: $551 · 2023: $514 · 2024: $578 · 2025: $826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,918.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,308.90 | 2019-2025 | Evos, Maverick, Real Intelligence |
| Advanced Orthopaedic Solutions, INC. | $2,138.66 | 2019 | |
| Stryker Corporation | $538.30 | 2019-2025 | Pangea, Axsos |
| Depuy Synthes Sales INC. | $250.27 | 2021-2025 | Na |
| Bone Support INC. | $130.20 | 2025 | Cerament G, Ceramentbone Void Filler |
| Capsovision, INC. | $93.80 | 2024 | Capsocam Plus |
| Acumed LLC | $55.07 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $39.96 | 2025 | Exparel, Iovera |
| Biocomposites INC | $28.59 | 2019 | |
| Pfizer INC. | $23.63 | 2025 | |
| Si-Bone, INC. | $21.86 | 2021 | |
| Zimmer Biomet Holdings, INC. | $20.37 | 2019 | |
| Amgen INC. | $16.09 | 2025 | Evenity, Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Clarke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.